MRDx BCR-ABL Test, MRDx BCR-ABL Test Software
Dec 2017
39d
MolecularMD Corporation
1
Total
0
Cleared
0
Denied
MolecularMD Corporation — FDA 510(k) Submissions
MolecularMD Corporation has submitted 1 FDA 510(k) premarket notifications since 2017, of which 0 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Bcr/abl1 Monitoring Test . Use the specialty filter in the sidebar to narrow results.
1 devices